Tech News
← Home  ·  All topics

Depression

5 GoKawiil briefs on this topic

Canadian youth mental health declines as depression and anxiety rise

Data shows an increase in depression and anxiety among Canadian men aged 15 to 24 over a decade, with self-reported mood disorders climbing from 11% to 16% and anxiety from 4% to 10%. Personal stories highlight the stigma and silence surrounding mental health struggles in young men, influenced by societal expectations of masculinity.

Researchers question Prozac evidence for child depression, cite 2006 Iran trial

A team led by psychiatrist Richard Lyus and researcher Florian Naudet published an analysis in Cochrane Evidence Synthesis and Methods arguing that a 2006 Iranian trial of 40 children had data flaws serious enough to undermine its reliability. They say this single study has disproportionately influenced clinical guidelines recommending fluoxetine (Prozac) for depression in children and adolescents, though they are not calling for doctors to stop prescribing it.

UC Davis study finds three minutes with donkeys eases teen anxiety

Researchers at UC Davis had 61 teenagers either stroke or neck-scratch rescued donkeys and miniature horses for a few minutes and measured their mood before and after. Participants reported feeling less anxious, sad and lonely, and calmer, almost immediately, with neck-scratching prompting more visible signs of pleasure from the animals such as lip-wriggling.

CDC data shows nearly 72% of U.S. adults report regular fatigue

A new CDC report finds that roughly 72% of American adults regularly experience fatigue, making it one of the most widespread health complaints nationwide. Researchers link this fatigue to higher rates of depression, anxiety, and cognitive difficulties among those affected.

Flow Neuroscience's at-home depression headset gets FDA clearance for US sale

Swedish company Flow Neuroscience has launched a prescription-only wearable device in the US designed to treat depression through daily brain stimulation at home. Worn on the forehead for 30 minutes a day and paired with a companion app, the headset delivers low-intensity electrical current to the brain's left frontal lobe, an area linked to mood regulation. The device received FDA approval in December and joins a growing category of consumer neurotech products that read or stimulate brain activity.